Clinical causes and treatment of the thrombotic storm

References

• Kearon C, Akl EA, Comerota AJ et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(Suppl. 2), 419S–494S (2012).
   Web of Science ®Google Scholar
• Vandvik PO, Lincoff AM, Gore JM et al.; American College of Chest Physicians. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(Suppl. 2), 637S–668S (2012).
   Web of Science ®Google Scholar
• Alonso-Coello P, Bellmunt S, McGorrian C et al.; American College of Chest Physicians. Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(Suppl. 2), 669S–690S (2012).
   Google Scholar
• Kwaan HC. Microvascular thrombosis: a serious and deadly pathologic process in multiple diseases. Semin. Thromb. Hemost. 37(8), 961–978 (2011).
   PubMedGoogle Scholar
• Andrew M, David M, Adams M et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 83(5), 1251–1257 (1994).
   PubMed Web of Science ®Google Scholar
• Monagle P, Newall F, Barnes C et al. Arterial thromboembolic disease: a single-centre case series study. J. Paediatr. Child Health 44(1–2), 28–32 (2008).
   PubMed Web of Science ®Google Scholar
• deVeber G, Andrew M, Adams C et al.; Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N. Engl. J. Med. 345(6), 417–423 (2001).
   PubMed Web of Science ®Google Scholar
• Kirkham F, Sébire G, Steinlin M, Sträter R. Arterial ischaemic stroke in children. Review of the literature and strategies for future stroke studies. Thromb. Haemost. 92(4), 697–706 (2004).
   PubMed Web of Science ®Google Scholar
• Raffini L, Raybagkar D, Cahill AM, Kaye R, Blumenstein M, Manno C. May-Thurner syndrome (iliac vein compression) and thrombosis in adolescents. Pediatr. Blood Cancer 47(6), 834–838 (2006).
   PubMed Web of Science ®Google Scholar
• Brandão LR, Williams S, Kahr WH, Ryan C, Temple M, Chan AK. Exercise-induced deep vein thrombosis of the upper extremity. 2. A case series in children. Acta Haematol. 115(3–4), 221–229 (2006).
   PubMed Web of Science ®Google Scholar
• Nowak-Göttl U, Junker R, Kreuz W et al.; Childhood Thrombophilia Study Group. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 97(4), 858–862 (2001).
   PubMed Web of Science ®Google Scholar
• Young G, Albisetti M, Bonduel M et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation 118(13), 1373–1382 (2008).
   PubMed Web of Science ®Google Scholar
• George JN. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989–2007). Kidney Int. Suppl. 112, 8–10 (2009).
   Google Scholar
• Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu. Rev. Pathol. 3, 249–277 (2008).
   PubMed Web of Science ®Google Scholar
• Asherson RA, Cervera R, Piette JC et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine 80(6), 355–377 (2001).
   PubMed Web of Science ®Google Scholar
• Kitchens CS. Thrombotic storm: when thrombosis begets thrombosis. Am. J. Med. 104(4), 381–385 (1998).
   PubMed Web of Science ®Google Scholar
• Kitchens CS, Erkan D, Brandão LR et al. Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group. Am. J. Med. 124(4), 290–296 (2011).
   PubMed Web of Science ®Google Scholar
• Hayashi T, Lee S, Ogasawara H et al. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus 7(8), 561–564 (1998).
   PubMed Web of Science ®Google Scholar
• Douglas KW, Pollock KG, Young D, Catlow J, Green R. Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a single-institution experience. J. Clin. Apher. 25(2), 47–53 (2010).
   PubMed Web of Science ®Google Scholar
• Cervera R, Bucciarelli S, Plasín MA et al.; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies). Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the ‘CAPS Registry’. J. Autoimmun. 32(3–4), 240–245 (2009).
   PubMed Web of Science ®Google Scholar
• Male C, Foulon D, Hoogendoorn H et al. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 106(13), 4152–4158 (2005).
   PubMed Web of Science ®Google Scholar
• Manco-Johnson MJ, Wang M, Goldenberg NA et al. Treatment, survival, and thromboembolic outcomes of thrombotic storm in children. J. Pediatr. 161(4), 682.e1–688.e1 (2012).
   Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4(2), 295–306 (2006).
   PubMed Web of Science ®Google Scholar
• Pengo V, Ruffatti A, Legnani C et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood 118(17), 4714–4718 (2011).
   PubMed Web of Science ®Google Scholar
• Warkentin TE. Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis. Ann. Intern. Med. 135(8 Pt 1), 589–593 (2001).
   PubMed Web of Science ®Google Scholar
• Moreb J, Kitchens CS. Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases. Am. J. Med. 87(2), 207–210 (1989).
   PubMed Web of Science ®Google Scholar
• Ingram SB, Goodnight SH Jr, Bennett RM. An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases. Arthritis Rheum. 30(10), 1167–1172 (1987).
   PubMedGoogle Scholar
• Bird AG, Lendrum R, Asherson RA, Hughes GR. Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities. Ann. Rheum. Dis. 46(3), 251–255 (1987).
   PubMed Web of Science ®Google Scholar
• Asherson RA. The catastrophic antiphospholipid syndrome. J. Rheumatol. 19(4), 508–512 (1992).
   PubMed Web of Science ®Google Scholar
• Erkan D, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun. Rev. 10(2), 74–79 (2010).
   PubMed Web of Science ®Google Scholar
• Cervera R, Khamashta MA, Shoenfeld Y et al.; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies). Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann. Rheum. Dis. 68(9), 1428–1432 (2009).
   PubMed Web of Science ®Google Scholar
• Bucciarelli S, Espinosa G, Cervera R. The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome. Lupus 18(10), 905–912 (2009).
   PubMed Web of Science ®Google Scholar
• Bayraktar UD, Erkan D, Bucciarelli S, Espinosa G, Asherson R; Catastrophic Antiphospholipid Syndrome Project Group. The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J. Rheumatol. 34(2), 346–352 (2007).
   PubMed Web of Science ®Google Scholar
• Erkan D, Asherson RA, Espinosa G et al.; Catastrophic Antiphospholipid Syndrome Registry Project Group. Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann. Rheum. Dis. 62(6), 530–533 (2003).
   PubMed Web of Science ®Google Scholar
• Warkentin TE, Makris M, Jay RM, Kelton JG. A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia. Am. J. Med. 121(7), 632–636 (2008).
   PubMed Web of Science ®Google Scholar
• Jay RM, Warkentin TE. Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of ‘spontaneous’ HIT? J. Thromb. Haemost. 6(9), 1598–1600 (2008).
   PubMed Web of Science ®Google Scholar
• Pruthi RK, Daniels PR, Nambudiri GS, Warkentin TE. Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery ‘spontaneous’ HIT. J. Thromb. Haemost. 7(3), 499–501 (2009).
   PubMed Web of Science ®Google Scholar
• Khorana AA. Cancer and coagulation. Am. J. Hematol. 87(Suppl. 1), 82–87 (2012).
   Google Scholar
• Majumder S, Thom T, Dasanu CA. Catastrophic arteriovenous thromboembolism as initial manifestation of pancreatic cancer. JOP 13(2), 231–234 (2012).
   PubMedGoogle Scholar
• Williams E, Smart SC, Go RS. Catastrophic thromboembolism in a patient with acute lymphoblastic leukemia and hypereosinophilia. Haematologica 89(4), EIM01 (2004).
   PubMedGoogle Scholar
• van Gestel JP, Merks JH, Lo RT, Kappelle JL, Braun KP. A child with multifocal arterial thrombosis. Thromb. Haemost. 93(5), 995–996 (2005).
   PubMed Web of Science ®Google Scholar
• Zöller B, Li X, Sundquist J, Sundquist K. Familial risks of unusual forms of venous thrombosis: a nationwide epidemiological study in Sweden. J. Intern. Med. 270(2), 158–165 (2011).
   PubMed Web of Science ®Google Scholar
• Sharma A, Itha S, Baijal SS, Gupta R, Sonkar A, Aggarwal R. Superior sagittal sinus thrombosis and Budd-Chiari syndrome due to paroxysmal nocturnal hemoglobinuria managed with transjugular intrahepatic portosystemic shunt: a case report. Trop. Gastroenterol. 26(3), 146–148 (2005).
   PubMedGoogle Scholar
• Kwon CM, Lee SH, Kim JH et al. A case of Behçet’s disease with pericarditis, thrombotic thrombocytopenic purpura, deep vein thrombosis and coronary artery pseudo aneurysm. Korean J. Intern. Med. 21(1), 50–56 (2006).
   PubMedGoogle Scholar
• Liu H, Al-Quran SZ, Lottenberg R. Thrombotic storm in Kimura disease. J. Thromb. Thrombolysis 29(3), 354–357 (2010).
   PubMed Web of Science ®Google Scholar
• Jeanneret C, Reutlinger C, Hirsch HH et al. Multifocal thrombophlebitis and deep vein thrombosis in primary cytomegalovirus infection–a histopathological analysis. Thromb. Haemost. 99(2), 445–447 (2008).
   PubMed Web of Science ®Google Scholar
• Ferri M, Faggioli G, Fratesi F, Stella A. Multifocal arterial thrombosis during thalidomide therapy: case report and review of the literature. Case Report. Med. 2009, 372073 (2009).
   PubMedGoogle Scholar
• Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb. Haemost. 94(1), 132–135 (2005).
   PubMed Web of Science ®Google Scholar
• Arepally GM, Ortel TL. Heparin-induced thrombocytopenia. Annu. Rev. Med. 61, 77–90 (2010).
   PubMed Web of Science ®Google Scholar
• Omran AS, Karimi A, Ahmadi H, Yazdanifard P. Delayed-onset heparin-induced thrombocytopenia presenting with multiple arteriovenous thromboses: case report. J. Med. Case Rep. 1, 131 (2007).
   PubMedGoogle Scholar
• Refaai MA, Warkentin TE, Axelson M, Matevosyan K, Sarode R. Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: a consequence of heparin ‘flushes’. Thromb. Haemost. 98(5), 1139–1140 (2007).
   PubMed Web of Science ®Google Scholar
• Zivelin A, Gitel S, Griffin JH et al. Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C. Blood 94(3), 895–901 (1999).
   PubMed Web of Science ®Google Scholar
• Hoylaerts MF, Thys C, Arnout J, Vermylen J. Recurrent arterial thrombosis linked to autoimmune antibodies enhancing von Willebrand factor binding to platelets and inducing Fc γ RII receptor-mediated platelet activation. Blood 91(8), 2810–2817 (1998).
   PubMed Web of Science ®Google Scholar
• Sarode R. Atypical presentations of thrombotic thrombocytopenic purpura: a review. J. Clin. Apher. 24(1), 47–52 (2009).
   PubMed Web of Science ®Google Scholar
• Imanirad I, Rajasekhar A, Zumberg M. A case series of atypical presentations of thrombotic thrombocytopenic purpura. J. Clin. Apher. 27(4), 221–226 (2012).
   PubMed Web of Science ®Google Scholar
• Josephson C, Nuss R, Jacobson L et al. The varicella-autoantibody syndrome. Pediatr. Res. 50(3), 345–352 (2001).
   PubMed Web of Science ®Google Scholar
• Manco-Johnson MJ, Nuss R, Key N et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J. Pediatr. 128(3), 319–323 (1996).
   PubMed Web of Science ®Google Scholar
• Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43(8), 1467–1472 (1993).
   PubMed Web of Science ®Google Scholar
• O’Roak BJ, Vives L, Girirajan S et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485(7397), 246–250 (2012).
   PubMed Web of Science ®Google Scholar